Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT00447824
Other study ID # S-06471a
Secondary ID
Status Recruiting
Phase N/A
First received March 13, 2007
Last updated March 13, 2007
Start date March 2007
Est. completion date November 2009

Study information

Verified date March 2007
Source Sorlandet Hospital HF
Contact Knut G Hernes, Dr
Phone +(47) 957 99999
Email drhernes@gmail.com
Is FDA regulated No
Health authority Norway:National Committee for Medical and Health Research Ethics
Study type Interventional

Clinical Trial Summary

Hypothesis:

1. May the introduction of NIDCAP during blood sample reduced pain in neonates during blood sample

2. Compare the effect of venous and capillary blood sample method


Description:

introducing the: Newborn Individualized Developmental Care and Assessment Program


Recruitment information / eligibility

Status Recruiting
Enrollment 160
Est. completion date November 2009
Est. primary completion date
Accepts healthy volunteers Accepts Healthy Volunteers
Gender Both
Age group 31 Weeks to 36 Weeks
Eligibility Inclusion Criteria:

- Born gestation age 31-36

Exclusion Criteria:

- Infection, respiratory distress

Study Design

Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Single Blind, Primary Purpose: Treatment


Related Conditions & MeSH terms


Intervention

Procedure:
Introduction of better conditions during blood sampling


Locations

Country Name City State
Norway Sorlandet Hospital SSHF Kristiansand Vest Agder

Sponsors (2)

Lead Sponsor Collaborator
Sorlandet Hospital HF Helse sor

Country where clinical trial is conducted

Norway, 

Outcome

Type Measure Description Time frame Safety issue
Primary value of Premature Infant Pain Profile
Primary Heart rate
Primary Saturation
Primary Skin conductance changes